Isolated brain metastases as the sole manifestation of a late relapse in breast cancer

Shumin Li, Xun Li, George J. Rozanski

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We report on a 62-year-old female patient suffering from breast cancer (invasive ductal, premenopausal, estrogen- and progesterone-receptor status unknown) first diagnosed in July 1991. After mastectomy and axillary lymphonodectomy (pT2 N2 (12/15) M0 G2), adjuvant chemotherapy consisting of six courses epirubicin and cyclophosphamide was performed. Since 1993, serum Ca 15-3 levels began to climb slowly. As of June 1996, Ca 15-3 was measured 50.1 U/ml (normal value <28.0 U/ml). In routine follow-ups, Ca 15-3 increased slowly, but no metastases of the breast cancer could be detected. In September 2000, the patient attended a routine follow-up examination with poor performance status, presenting with ataxia and a psychic syndrome. Computed tomography revealed multiple suprasellar brain metastases. We conclude that this is an unusual case of a very late clinical manifestation of sole brain metastases in a patient with breast cancer. A slow preceding increase of Ca 15-3-level over a period of 7 years was the only indicator of the upcoming brain metastases.

Original languageEnglish (US)
Pages (from-to)61-63
Number of pages3
JournalJournal of Cancer Research and Clinical Oncology
Volume128
Issue number1
DOIs
StatePublished - Jan 1 2002

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Recurrence
Brain
Epirubicin
Mastectomy
Progesterone Receptors
Ataxia
Adjuvant Chemotherapy
Estrogen Receptors
Cyclophosphamide
Reference Values
Tomography
Serum

Keywords

  • Brain metastases
  • Breast cancer
  • Ca 15-3

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Isolated brain metastases as the sole manifestation of a late relapse in breast cancer. / Li, Shumin; Li, Xun; Rozanski, George J.

In: Journal of Cancer Research and Clinical Oncology, Vol. 128, No. 1, 01.01.2002, p. 61-63.

Research output: Contribution to journalArticle

@article{4d7fd50d2e4545f8a2502f15c66101cf,
title = "Isolated brain metastases as the sole manifestation of a late relapse in breast cancer",
abstract = "We report on a 62-year-old female patient suffering from breast cancer (invasive ductal, premenopausal, estrogen- and progesterone-receptor status unknown) first diagnosed in July 1991. After mastectomy and axillary lymphonodectomy (pT2 N2 (12/15) M0 G2), adjuvant chemotherapy consisting of six courses epirubicin and cyclophosphamide was performed. Since 1993, serum Ca 15-3 levels began to climb slowly. As of June 1996, Ca 15-3 was measured 50.1 U/ml (normal value <28.0 U/ml). In routine follow-ups, Ca 15-3 increased slowly, but no metastases of the breast cancer could be detected. In September 2000, the patient attended a routine follow-up examination with poor performance status, presenting with ataxia and a psychic syndrome. Computed tomography revealed multiple suprasellar brain metastases. We conclude that this is an unusual case of a very late clinical manifestation of sole brain metastases in a patient with breast cancer. A slow preceding increase of Ca 15-3-level over a period of 7 years was the only indicator of the upcoming brain metastases.",
keywords = "Brain metastases, Breast cancer, Ca 15-3",
author = "Shumin Li and Xun Li and Rozanski, {George J.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1007/s004320100286",
language = "English (US)",
volume = "128",
pages = "61--63",
journal = "Zeitschrift fur Krebsforschung und Klinische Onkologie",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Isolated brain metastases as the sole manifestation of a late relapse in breast cancer

AU - Li, Shumin

AU - Li, Xun

AU - Rozanski, George J.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - We report on a 62-year-old female patient suffering from breast cancer (invasive ductal, premenopausal, estrogen- and progesterone-receptor status unknown) first diagnosed in July 1991. After mastectomy and axillary lymphonodectomy (pT2 N2 (12/15) M0 G2), adjuvant chemotherapy consisting of six courses epirubicin and cyclophosphamide was performed. Since 1993, serum Ca 15-3 levels began to climb slowly. As of June 1996, Ca 15-3 was measured 50.1 U/ml (normal value <28.0 U/ml). In routine follow-ups, Ca 15-3 increased slowly, but no metastases of the breast cancer could be detected. In September 2000, the patient attended a routine follow-up examination with poor performance status, presenting with ataxia and a psychic syndrome. Computed tomography revealed multiple suprasellar brain metastases. We conclude that this is an unusual case of a very late clinical manifestation of sole brain metastases in a patient with breast cancer. A slow preceding increase of Ca 15-3-level over a period of 7 years was the only indicator of the upcoming brain metastases.

AB - We report on a 62-year-old female patient suffering from breast cancer (invasive ductal, premenopausal, estrogen- and progesterone-receptor status unknown) first diagnosed in July 1991. After mastectomy and axillary lymphonodectomy (pT2 N2 (12/15) M0 G2), adjuvant chemotherapy consisting of six courses epirubicin and cyclophosphamide was performed. Since 1993, serum Ca 15-3 levels began to climb slowly. As of June 1996, Ca 15-3 was measured 50.1 U/ml (normal value <28.0 U/ml). In routine follow-ups, Ca 15-3 increased slowly, but no metastases of the breast cancer could be detected. In September 2000, the patient attended a routine follow-up examination with poor performance status, presenting with ataxia and a psychic syndrome. Computed tomography revealed multiple suprasellar brain metastases. We conclude that this is an unusual case of a very late clinical manifestation of sole brain metastases in a patient with breast cancer. A slow preceding increase of Ca 15-3-level over a period of 7 years was the only indicator of the upcoming brain metastases.

KW - Brain metastases

KW - Breast cancer

KW - Ca 15-3

UR - http://www.scopus.com/inward/record.url?scp=0036178582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036178582&partnerID=8YFLogxK

U2 - 10.1007/s004320100286

DO - 10.1007/s004320100286

M3 - Article

VL - 128

SP - 61

EP - 63

JO - Zeitschrift fur Krebsforschung und Klinische Onkologie

JF - Zeitschrift fur Krebsforschung und Klinische Onkologie

SN - 0171-5216

IS - 1

ER -